Real‐World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus‐Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT

20260 citationsJournal Article

Authors

Jan Styczynski · Nicolaus Copernicus University

Gloria Tridello · European Society for Blood and Marrow Transplantation

Nina Knelange · European Society for Blood and Marrow Transplantation

Lotus Wendel · European Society for Blood and Marrow Transplantation

Per Ljungman · Karolinska University Hospital

Dina Averbuch · Hebrew University of Jerusalem

Domenico Russo

Abstract

An analysis of real-world use of letermovir in CMV prophylaxis after allo-HCT showed a low incidence of csCMVi compared to previously published information.

Topics & Keywords

Cytomegalovirus and herpesvirus research Parvovirus B19 Infection Studies Virus-based gene therapy research

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Transplant Infectious Disease

DOI: 10.1111/tid.70196

Field-Weighted Citation Impact: 0.00